期刊文献+

2010年至2013年我院鲍曼不动杆菌耐药趋势分析 被引量:8

Acinetobacter Baumannii Drug Resistance Trend in Our Hospital from 2010 to 2013
下载PDF
导出
摘要 目的了解医院鲍曼不动杆菌感染的临床分布和耐药现状,为规范临床合理应用抗菌药物提供依据。方法对医院2010年至2013年临床各科室送检标本中分离的580株鲍曼不动杆菌药物敏感性试验结果进行统计和分析。结果 4年来,微生物送检标本共计88 715例,检出鲍曼不动杆菌580株,占致病菌总数的1.63%;检出鲍曼不动杆菌的标本83.10%来源于痰液;215株鲍曼不动杆菌来自重症监护病房(ICU),占所有感染病区的37.07%,其次是神经内科76株(13.10%);对抗菌药物敏感(S)、多重耐药(NDR)、广泛耐药(XDR)菌株、全耐药(PDR)的菌株分别占检出鲍曼不动杆菌总数的19.83%,8.45%,16.90%,54.83%;ICU全耐药菌株占全耐药菌株总数的47.16%;鲍曼不动杆菌对亚胺培南的敏感率最高。结论鲍曼不动杆菌的耐药现象非常严重,且耐药率呈逐年上升趋势,需加强鲍曼不动杆菌耐药监测和临床合理应用抗菌药物管理,重视医院环境、工作人员消毒,遏制鲍曼不动杆菌在医院内的传播和流行。 Objective To understand the clinical distribution and drug resistance situation of Acinetobacter baumannii(AB) infection so as to provide the basis for standardizing clinical rational use of antibacterial drugs. Methods The drug susceptibility test results in 580 strains of AB isolated from the specimens submitted by the clinical departments from 2010 to 2013 were performed the statistical analysis. Results 88 715 specimens for conducting microbiological inspection were submitted during these 4 years. 580 strains of AB were detected out,accounting for 1.63% of total pathogenic bacteria;83.10% of specimens with AB detection was originated from sputum; 215 strains of AB were origenated from ICU,accounting for 37.07% of all infection wards,secondly 76 strains(13.10% ) from the neurological department; strains with the sensitivity to antibacterial drugs(S), multi-drug resistance(NDR),extensively drug resistance (XDR) and pan-drug resistance(PDR) accounted for 19.83% ,8.45% ,16.90% and 54. 83% of the total detected AB respectively; PDR from ICU accounted for 47.16% of the total number of drug-resistant strains;AB had the highest susceptibility rate to imipenem. Conclusion The drug resistance phenomenon of AB is very serious,moreover its drug resistance rate exhibits the increasing rend year by year;the AB drug resistance monitoring and the management of clinical rational use of antimicrobial drugs should be strengthened; more attention should be paid to the hospital environment and staff disinfection for restrainting AB spread and prevalence in hospital.
出处 《中国药业》 CAS 2014年第18期89-92,共4页 China Pharmaceuticals
关键词 鲍曼不动杆菌 多重耐药 广泛耐药 全耐药 抗菌药物 Acinetobacter baumannii (AB) multi - drug resistance (NDR) extensively drug resistance (XDR) pan - drug resistance (PDR) antimicrobial agents
  • 相关文献

参考文献8

二级参考文献85

  • 1王传清,王爱敏,张泓,李万华,孙自镛,简翠,徐英春,孙宏莉,俞云松,杨青,胡云建,艾效曼,倪语星,孙景勇,汪复,胡付品,朱德妹,张朝霞,季萍,徐元宏,沈继录,卓超,苏丹虹,魏莲花,吴玲,单斌,杜艳,黄文祥,贾蓓.2009年中国CHINET链球菌属细菌耐药性监测[J].中国感染与化疗杂志,2010,10(6):426-429. 被引量:30
  • 2潘晓龙,周东升,吴祥林,方平.从携带多种耐药基因认识鲍曼不动杆菌多重耐药性[J].江西医学检验,2006,24(1):3-6. 被引量:12
  • 3杜小幸,张幸国,周华,俞云松,陈亚岗,李兰娟.亚胺培南耐药鲍曼不动杆菌同源性及碳青霉烯酶研究[J].中国感染与化疗杂志,2006,6(4):231-235. 被引量:47
  • 4杨启文,王辉,徐英春,谢秀丽,孙宏莉,陈民钧.3种常见非发酵革兰阴性杆菌的体外药物敏感性[J].中国感染与化疗杂志,2007,7(3):198-201. 被引量:14
  • 5Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing, twentieth informational supplement[S]. M100-S20. CLSI,2010.
  • 6Musta AC, Riederer K, Shemes S, et al. Vancomycin MIC plus heteroresistance and outcome of methieillin resistant Staphy lococcus aureus bacteremia: trends over 11 years[J]. Clin Mi- crobiol, 2009,47(6) : 1640-1644.
  • 7Schwaber MJ,Navon-Venezia S,Carmeli Y. High level of an- timicrobial co resistance among extended-spectrum t?-lacta- mase producing Enterobacteriaceae [J]. Antimicrob Agents Chemother,2005,49(5):2137-2139.
  • 8Nordmann P,Cuzon G, Naas T. The real threat of Klebsiella pneumoniae earbapenemase-producing bacteria[J]. Lancet In fect Dis, 2009,9(4) :228-236.
  • 9Cai JC,Zhou HW,Zhang R, et al. Emergence of Serratia marces cens, Klebsiella pneumoniae , and Escherichia coli isolates posses sing the plasmid mediated carbapenem hydrolyzing beta-lactamase KPC2 in intensive care units of a Chinese hospital[J]. Antimicrob Agents Chemother, 2008,52 (6):2014- 2018.
  • 10McGowan JE.Resistance in nonfermenting gram-negativebacteria:multidrug resistance to the maximum[J].Associa-tion for Professionals in Infection Control and Epidemiology,2006,34(suppl.1):S29-S37.

共引文献242

同被引文献72

  • 1张永,唐英春,陆坚,张扣兴.鲍曼不动杆菌对亚胺培南耐药分子机制的研究[J].中国抗生素杂志,2005,30(4):217-221. 被引量:71
  • 2文远大,谭芳,吴碧桃.药学监护参与抗菌药物合理应用的对照研究[J].中国药业,2007,16(5):43-44. 被引量:2
  • 3石岩,刘大为,许大波,徐英春,陈民均,王辉.泛耐药鲍曼不动杆菌感染临床治疗初探[J].中国感染与化疗杂志,2007,7(1):34-37. 被引量:112
  • 4Tunkel AR, Hartman B J, Kaplan SL, et al. Practice guildlines for the management of bactetial meningitis [ J ]. C lin Infect Dis, 2004, 39 (9) : 1 267-1 284,.
  • 5Cunha BA. Optimal therapy for multidmg- resistant Acinetobacter bau- mannii [J]. Emerg Infect Dis, 2010,16 ( 1 ) : 170.
  • 6Perez F, Hujer AM, Hujer KM, et al. Global Challenge of Multidrug - Re- sistant Acinetobacter baumannii[J]. Antiraicrob Agents Chemother, 2007, 51(10): 3 471 -3 484.
  • 7周良辅,周建新,李光辉,等.万古霉素临床应用中国专家共识(2011版)(中枢神经系统感染)[J].中国新药与临床杂志,2011,30(8):566-567.
  • 8BartlettJG,AuwaerterPG,PhamPA.感染性疾病的诊断与治疗[M].第2版.马小军,徐英春,刘正印,译.北京:科学技术文献出版社,2012:184—186.
  • 9Luna CM, Aruj PK. Nosocomial Acinetobacter pneumonia[J] . Respirology, 2007,12:787 - 791.
  • 10White R, Bradnam V. Handbook of Drug Administration via Enter- al Feeding Tubes [M]. UK: RPS Publishing,2007 : 84,240.

引证文献8

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部